Publication | Closed Access

A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure

UrologyRenal FunctionPlasma LevelsMedicineKidney FailureRenal PathologyPathologyDialysis TherapyChronic Kidney DiseaseTerminal Renal FailureNephrologyKidney ResearchNovel Endogenous Digitalis